Abstract
It is difficult to differentiate some malignant peripheral nerve sheath tumors (MPNST) from benign peripheral nerve sheath tumors (BPNST) histologically, and to predict the clinical outcome of patients with MPNST. In this study, the expression of VEGF and MVD were evaluated immunohistochemically in 22 cases of MPNST, 14 of neurofibroma and 19 of schwannoma and correlation of the staining grade of VEGF or MVD and the various clinical factors were analyzed, and statistically evaluated. Levels of VEGF mRNA expression were also determined with real-time RT-PCR. Statistically higher positive staining for VEGF was observed in MPNST compared to neurofibroma (P = 0.004) and schwannoma (P < 0.001). Even low grade MPNST showed higher VEGF positive staining than neurofibroma. Moreover, high VEGF expression statistically correlated with the poor prognosis of the patients with MPNST (P = 0.015). Although MVD in MPNST was significantly higher than that in neurofibroma (P = 0.038) and schwannoma (P < 0.001), MVD could not predict the prognosis of the patients with MPNST. Although VEGF mRNA expression tended to be higher in MPNST compared to neurofibroma, the difference was not significant. Levels of VEGF protein expression serve as a novel diagnostic and prognostic tools for peripheral nerve sheath tumors.
Similar content being viewed by others
Abbreviations
- MPNST:
-
Malignant peripheral nerve sheath tumors
- BPNST:
-
Benign peripheral nerve sheath tumors
- VEGF:
-
Vascular endothelial growth factor
- MVD:
-
Micro vessel density
- NF1:
-
Neurofibromatosis type 1
- GAPDH:
-
Glyceraldehyde-3-phosphate dehydrogenase
- NED:
-
No evidence of disease
- AWD:
-
Alive with disease
- DOD:
-
Died of disease
References
Enzinger FM, Weiss SW (2001) Malignant tumors of peripheral nerves. In: Enzinger FM, Weiss SW (eds) Soft tissue tumors. CV Mosby Company, St. Louis, pp 1209–1263
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182–1186
Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82(1):4–6
Borre M, Offersen BV, Nerstrom B, Overgaard J (1998) Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 78(7):940–944
Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis—correlation in invasive breast carcinoma. N Engl J Med 324(1):1–8
Choi JY, Jang KT, Shim YM, Kim K, Ahn G, Lee KH, Choi Y, Choe YS, Kim BT (2006) Prognostic significance of vascular endothelial growth factor expression and microvessel density in esophageal squamous cell carcinoma: comparison with positron emission tomography. Ann Surg Oncol 13:1054–1062
Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostini B, Pignatelli C (2004) Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res 10:3490–3499
Giatromanolaki A, Sivridis E, Brekken R, Thorpe PE, Anastasiadis P, Gatter KC, Harris AL, Koukourakis MI (2001) The angiogenic “vascular endothelial growth factor/flk-1(KDR) receptor” pathway in patients with endometrial carcinoma: prognostic and therapeutic implications. Cancer 92:2569–2577
Imamura M, Yamamoto H, Nakamura N, Oda Y, Yao T, Kakeji Y, Baba H, Maehara Y, Tsuneyoshi M (2007) Prognostic significance of angiogenesis in gastrointestinal stromal tumor. Mod Pathol 20:529–537
Mineo TC, Ambrogi V, Baldi A, Rabitti C, Bollero P, Vincenzi B, Tonini G (2004) Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol 57:591–597
Miracco C, Montesco MC, Santopietro R, Spina D, d’Amore ES, Tosi P, Ninfo V (1996) Proliferative activity, angiogenesis, and necrosis in peripheral nerve sheath tumors: a quantitative evaluation for prognosis. Mod Pathol 9:1108–1117
Arbiser JL, Flynn E, Barnhill RL (1998) Analysis of vascularity of human neurofibromas. J Am Acad Dermatol 38:950–954
Kawachi Y, Xu X, Ichikawa E, Imakado S, Otsuka F (2003) Expression of angiogenic factors in neurofibromas. Exp Dermatol 12(4):412–417
Lin BT, Weiss LM, Medeiros LJ (1997) Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors. Am J Surg Pathol 21:1443–1449
DuBois S, Demetri G (2007) Markers of angiogenesis and clinical features in patients with sarcoma. Cancer 109(5):813–819
Saenz NC, Heslin MJ, Adsay V, Lewis JJ, Leung DH, LaQuaglia MP, Brennan MF (1998) Neovascularity and clinical outcome in high-grade extremity soft tissue sarcomas. Ann Surg Oncol 5:48–53
Yudoh K, Kanamori M, Ohmori K, Yasuda T, Aoki M, Kimura T (2001) Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas. Br J Cancer 84:1610–1615
Chao C, Al-Saleem T, Brooks JJ, Rogatko A, Kraybill WG, Eisenberg B (2001) Vascular endothelial growth factor and soft tissue sarcomas: tumor expression correlates with grade. Ann Surg Oncol 8:260–267
Pakos EE, Goussia AC, Tsekeris PG, Papachristou DJ, Stefanou D, Agnantis NJ (2005) Expression of vascular endothelial growth factor and its receptor, KDR/Flk-1, in soft tissue sarcomas. Anticancer Res 25:3591–3596
Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, Higashino F, Mezawa F, Okada F, Ishii S (2000) Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 6:572–577
Kreuter M, Paulussen M, Boeckeler J, Gerss J, Buerger H, Liebscher C, Kessler T, Jurgens H, Berdel WE, Mesters RM (2006) Clinical significance of vascular endothelial growth factor-A expression in Ewing’s sarcoma. Eur J Cancer 42(12):1904–1911
Kreuter M, Bieker R, Bielack SS, Auras T, Buerger H, Gosheger G, Jurgens H, Berdel WE, Mesters RM (2004) Prognostic relevance of increased angiogenesis in osteosarcoma. Clin Cancer Res 10:8531–8537
Charity RM, Foukas AF, Deshmukh NS, Grimer RJ (2006) Vascular endothelial growth factor expression in osteosarcoma. Clin Orthop Relat Res 448:193–198
Mantadakis E, Kim G, Reisch J, McHard K, Maale G, Leavey PJ, Timmons C (2001) Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma. J Pediatr Hematol Oncol 23:286–289
Wang D, Chen L, Gao F (1997) [Correlation of tumor microvesseldensity with prognosis in osteogenic sarcoma]. Zhonghua Bing Li Xue Za Zhi 26:266–269
Anghileri M, Miceli R, Fiore M, Mariani L, Ferrari A, Mussi C, Lozza L, Collini P, Olmi P, Casali PG, Pilotti S, Gronchi A (2006) Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer 107(5):1065–1074
Baehring JM, Betensky RA, Batchelor TT (2003) Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology 61(5):696–698
Cashen DV, Parisien RC, Raskin K, Hornicek FJ, Gebhardt MC, Mankin HJ (2004) Survival data for patients with malignant schwannoma. Clin Orthop Relat Res 426:69–73
Kar M, Deo SS, Shukla NK, Malik A, Dattagupta S, Mohanti BK, Thulkar S (2006) Malignant peripheral nerve sheath tumors (MPNST)—clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol 4:55
Okada K, Hasegawa T, Tajino T, Hotta T, Yanagisawa M, Osanai T, Nishida J, Seki K, Itoi E (2007) Clinical relevance of pathological grades of malignant peripheral nerve sheath tumor: a multi-institution TMTS study of 56 cases in Northern Japan. Ann Surg Oncol 14(2):597–604
Wanebo JE, Malik JM, VandenBerg SR, Wanebo HJ, Driesen N, Persing JA (1993) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 71(4):1247–1253
Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL (1998) Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42(2):351–360
Acknowledgements
We thank Mr. Hiroshi Yamada for technical assistance to make tissue sections, and Miss Eri Ishihara for secretarial assistance. This work was supported in part by The Nakatomi Foundation, and by the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid 20591751 for Scientific Research (C)].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wasa, J., Nishida, Y., Suzuki, Y. et al. Differential expression of angiogenic factors in peripheral nerve sheath tumors. Clin Exp Metastasis 25, 819–825 (2008). https://doi.org/10.1007/s10585-008-9197-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-008-9197-8